TimesSquare Capital Management LLC Increases Stake in Stevanato Group S.p.A. (NYSE:STVN)

TimesSquare Capital Management LLC grew its position in Stevanato Group S.p.A. (NYSE:STVN) by 114.6% during the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm owned 3,288,529 shares of the company’s stock after acquiring an additional 1,756,100 shares during the quarter. TimesSquare Capital Management LLC owned about 1.09% of Stevanato Group worth $71,657,000 at the end of the most recent reporting period.

Several other hedge funds and other institutional investors have also made changes to their positions in the company. Hardy Reed LLC increased its stake in Stevanato Group by 8.2% in the 3rd quarter. Hardy Reed LLC now owns 11,077 shares of the company’s stock worth $222,000 after buying an additional 840 shares during the period. Lindenwold Advisors INC increased its stake in Stevanato Group by 13.5% in the 3rd quarter. Lindenwold Advisors INC now owns 11,930 shares of the company’s stock worth $239,000 after buying an additional 1,415 shares during the period. Raymond James Trust N.A. increased its stake in Stevanato Group by 22.6% in the 3rd quarter. Raymond James Trust N.A. now owns 12,556 shares of the company’s stock worth $251,000 after buying an additional 2,317 shares during the period. Captrust Financial Advisors increased its stake in Stevanato Group by 12.7% in the 3rd quarter. Captrust Financial Advisors now owns 13,100 shares of the company’s stock worth $262,000 after buying an additional 1,480 shares during the period. Finally, First Bank & Trust increased its stake in Stevanato Group by 29.1% in the 3rd quarter. First Bank & Trust now owns 14,109 shares of the company’s stock worth $282,000 after buying an additional 3,182 shares during the period.

Stevanato Group Trading Up 3.4 %

NYSE STVN opened at €20.20 ($21.04) on Wednesday. The company has a debt-to-equity ratio of 0.22, a quick ratio of 1.21 and a current ratio of 1.81. The company has a market capitalization of $6.12 billion, a price-to-earnings ratio of 42.98, a price-to-earnings-growth ratio of 6.86 and a beta of 0.56. The company’s 50-day simple moving average is €21.89 and its two-hundred day simple moving average is €20.53. Stevanato Group S.p.A. has a one year low of €16.56 ($17.25) and a one year high of €34.00 ($35.42).

Wall Street Analysts Forecast Growth

STVN has been the topic of several recent analyst reports. Morgan Stanley reaffirmed an “equal weight” rating and issued a $23.00 price target (down previously from $24.00) on shares of Stevanato Group in a research note on Tuesday, December 3rd. Bank of America raised their price target on shares of Stevanato Group from $24.00 to $26.00 and gave the stock a “buy” rating in a research note on Friday, December 13th. Finally, Wolfe Research assumed coverage on shares of Stevanato Group in a research note on Friday, December 13th. They issued an “outperform” rating and a $28.00 price target on the stock. One research analyst has rated the stock with a hold rating and five have issued a buy rating to the company’s stock. According to MarketBeat.com, Stevanato Group has a consensus rating of “Moderate Buy” and a consensus price target of €28.60 ($29.79).

Stevanato Group Profile

Stevanato Group S.p.A. engages in the design, production, and distribution of products and processes to provide integrated solutions for bio-pharma and healthcare industries in Europe, the Middle East, Africa, North America, South America, and the Asia Pacific. The company operates in two segments, Biopharmaceutical and Diagnostic Solutions; and Engineering.